Related Experiment Video

Updated: May 22, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K

Mitochondria-associated non-coding RNAs and their impact on drug resistance

Xingna An1, Lina Sun2, Huan Zheng2

  • 1Department of Core Facility, The First Hospital of Jilin University, Changchun, Jilin, China.

Frontiers in Pharmacology
|March 13, 2025
PubMed

Insights

Mitochondria and their non-coding RNAs (mtncRNAs) significantly impact drug resistance by regulating cellular energy and drug sensitivity. Understanding mtncRNA mechanisms offers new strategies to overcome treatment challenges.

Area of Science:

  • Mitochondrial biology
  • Molecular mechanisms of drug resistance
  • Non-coding RNA therapeutics

Background:

  • Drug resistance leads to treatment failure and poor patient outcomes.
  • Mitochondria play a critical role in regulating cellular drug sensitivity.
  • Mitochondrial functions like ROS production and OXPHOS are linked to drug resistance.

Purpose of the Study:

  • To review the role of mitochondrial non-coding RNAs (mtncRNAs) in drug resistance.
  • To elucidate the molecular mechanisms by which mtncRNAs influence drug sensitivity.
  • To provide insights for developing novel strategies against drug resistance.

Main Methods:

  • Literature review of studies on mtncRNAs and drug resistance.
  • Analysis of molecular pathways involving mitochondrial function and ncRNAs.
  • Synthesis of current knowledge on mtncRNA regulation of drug sensitivity.

Main Results:

  • mtncRNAs, from mtDNA or nuclear origins, modulate mitochondrial gene expression and function.
  • These mtncRNAs affect mitochondrial substance exchange and energy metabolism, influencing drug sensitivity.
  • Specific mtncRNAs are associated with various types of drug resistance.

Conclusions:

  • mtncRNAs are key regulators of cellular drug sensitivity and resistance.
  • Targeting mtncRNAs presents a promising therapeutic avenue for overcoming drug resistance.
  • Further research into mtncRNA mechanisms can guide the development of effective treatments.
Keywords:
cancerdrug resistancelncRNAmicroRNAmitochondria

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.6K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.3K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
227